To see the other types of publications on this topic, follow the link: Plasma therapy.

Journal articles on the topic 'Plasma therapy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Plasma therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

GIBSON, J., and D. JOSHUA. "Plasma exchange therapy." Australian and New Zealand Journal of Medicine 28, no. 6 (1998): 839. http://dx.doi.org/10.1111/j.1445-5994.1998.tb01569.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

PUSSELL, B. A. "Plasma exchange therapy." Australian and New Zealand Journal of Medicine 28, no. 3 (1998): 289–90. http://dx.doi.org/10.1111/j.1445-5994.1998.tb01949.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Privat-Maldonado, Angela, Anke Schmidt, Abraham Lin, et al. "ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy." Oxidative Medicine and Cellular Longevity 2019 (October 8, 2019): 1–29. http://dx.doi.org/10.1155/2019/9062098.

Full text
Abstract:
Physical plasmas generate unique mixes of reactive oxygen and nitrogen species (RONS or ROS). Only a bit more than a decade ago, these plasmas, operating at body temperature, started to be considered for medical therapy with considerably little mechanistic redox chemistry or biomedical research existing on that topic at that time. Today, a vast body of evidence is available on physical plasma-derived ROS, from their spatiotemporal resolution in the plasma gas phase to sophisticated chemical and biochemical analysis of these species once dissolved in liquids. Data from in silico analysis dissec
APA, Harvard, Vancouver, ISO, and other styles
4

Lamzalah, Yassine, Kawtar Nassar, Wafae Rachidi, Saadia Janani, and Ouafa Mkinsi. "Platelet-rich plasma therapy in rheumatology." Batna Journal of Medical Sciences (BJMS) 3, no. 2 (2016): 80–85. http://dx.doi.org/10.48087/bjmsra.2016.3205.

Full text
Abstract:
La plupart des études concernant le rôle du plasma riche en plaquettes (PRP) dans le traitement des tendinopathies démontre une amélioration de la symptomatologie suite au traitement. Néanmoins, de nombreux biais notamment le manque d’effectif, l’absence de groupe témoin ou encore le type variable de produit utilisé ne leur confèrent pas un niveau d’évidence assez élevé. À ce jour, les résultats obtenus in vivo ne permettent pas de recommander formellement l’utilisation du PRP dans le cadre du traitement des tendinopathies. La standardisation des techniques de fabrication, ainsi que celles des
APA, Harvard, Vancouver, ISO, and other styles
5

Utomo, Yeodi, Wayan Wahyu Semara Putra, and Ni Made Dwita Yaniswari. "Convalescent Plasma Therapy in Severe COVID-19 Patients: Retrospective Study." International Journal of Science and Research (IJSR) 10, no. 8 (2021): 105–7. https://doi.org/10.21275/sr21731125334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Diwan, Rajkumar, FM Debta, Abhijeet Deoghare, et al. "Plasma Therapy: An Overview." Journal of Indian Academy of Oral Medicine and Radiology 23 (April 2011): 120–23. http://dx.doi.org/10.5005/jp-journals-10011-1109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Manner, Hendrik. "Argon plasma coagulation therapy." Current Opinion in Gastroenterology 24, no. 5 (2008): 612–16. http://dx.doi.org/10.1097/mog.0b013e32830bf825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gujrathi, Ashish. "Plasma Therapy Gains Attention in Treatment of Viral Infections, Dermatological Illness, and Orthopedic Illnesses." Journal of Clinical Research and Reports 10, no. 4 (2022): 01–03. http://dx.doi.org/10.31579/2690-1919/234.

Full text
Abstract:
Plasma therapy is one of the major chapters in medicines. Convalescent plasma therapy, another term for plasma therapy involves the use of blood from a person who has recovered from a particular illness to help others who are suffering from the same disease. The plasma of this blood is likely to contain antibodies that can help other patients fight the same illness, especially if viruses or pathogens are compromising the immunity system. Plasma therapy speeds up the recovery and helps manage symptoms. Moreover, it is used in wound healing, face rejuvenation, and androgenetic alopecia. It can h
APA, Harvard, Vancouver, ISO, and other styles
9

Holmes Gobel, Barbara. "Plasma and plasma derivative therapy for coagulation disorders." Seminars in Oncology Nursing 6, no. 2 (1990): 129–35. http://dx.doi.org/10.1016/s0749-2081(05)80146-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kallingal, Anoop. "COVID-19: Plasma Therapy and Stem Cell Therapy." International Journal of Current Research and Review 13, no. 07 (2021): 01–02. http://dx.doi.org/10.31782/ijcrr.2021.13735.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Pietrini, Domenico, Daniele De Luca, Federica Tosi, et al. "Plasma Substitutes Therapy in Pediatrics." Current Drug Targets 13, no. 7 (2012): 893–99. http://dx.doi.org/10.2174/138945012800675669.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Han, Yong, James Fortenberry, Joseph Carcillo, and Trung Nguyen. "Plasma exchange therapy in sepsis." Journal of Pediatric Infectious Diseases 04, no. 02 (2015): 137–45. http://dx.doi.org/10.3233/jpi-2009-0155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Flahive, S. "Platelet Rich Plasma therapy–PRP." Journal of Science and Medicine in Sport 15 (December 2012): S135—S136. http://dx.doi.org/10.1016/j.jsams.2012.11.327.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Brunner, R., and H. Borberg. "Plasma exchange therapy in ophthalmology." Plasma Therapy and Transfusion Technology 9, no. 1 (1988): 59–61. http://dx.doi.org/10.1016/0278-6222(88)90033-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Daeschlein, Georg, Claudia Sicher, Sebastian von Podewils, Rico Rutkowski, and Michael Jünger. "Plasma Cancer Therapy In Dermatology." Clinical Plasma Medicine 9 (February 2018): 18–19. http://dx.doi.org/10.1016/j.cpme.2017.12.029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Wile, Alan. "Plasma Ultrafiltration as Cancer Therapy." Archives of Surgery 124, no. 2 (1989): 222. http://dx.doi.org/10.1001/archsurg.1989.01410020096015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Makroo, R. N. "Plasma therapy in HELLP syndrome." Apollo Medicine 9, no. 3 (2012): 276. http://dx.doi.org/10.1016/j.apme.2012.06.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Tanaka, Hiromasa, Masaaki Mizuno, Kenji Ishikawa, et al. "Plasma Medical Science for Cancer Therapy: Toward Cancer Therapy Using Nonthermal Atmospheric Pressure Plasma." IEEE Transactions on Plasma Science 42, no. 12 (2014): 3760–64. http://dx.doi.org/10.1109/tps.2014.2353659.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

KOGA, Shin, and Toshimasa UCHIYAMA. "Replacement therapy platelet concentrates, fresh frozen plasma, fibrinogen therapy." Japanese Journal of Thrombosis and Hemostasis 17, no. 3 (2006): 308–13. http://dx.doi.org/10.2491/jjsth.17.308.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Badria, Amelia A., and Mardoni Setiawan. "Platelet-Rich Plasma Therapy for Chronic Angiopathy non-Diabetic Wounds: A Case Study." International Journal of Research Publication and Reviews 6, no. 2 (2025): 2863–67. https://doi.org/10.55248/gengpi.6.0225.0933.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Karki, Surya B., Eda Yildirim-Ayan, Kathryn M. Eisenmann, and Halim Ayan. "Miniature Dielectric Barrier Discharge Nonthermal Plasma Induces Apoptosis in Lung Cancer Cells and Inhibits Cell Migration." BioMed Research International 2017 (2017): 1–12. http://dx.doi.org/10.1155/2017/8058307.

Full text
Abstract:
Traditional cancer treatments like radiotherapy and chemotherapy have drawbacks and are not selective for killing only cancer cells. Nonthermal atmospheric pressure plasmas with dielectric barrier discharge (DBD) can be applied to living cells and tissues and have emerged as novel tools for localized cancer therapy. The purpose of this study was to investigate the different effects caused by miniature DBD (mDBD) plasma to A549 lung cancer cells. In this study, A549 lung cancer cells cultured in 12 well plates were treated with mDBD plasma for specified treatment times to assess the changes in
APA, Harvard, Vancouver, ISO, and other styles
22

Heena Bholaram Choudhary, Rohan Rajkumar Patekar, Akshita Pramod Jain, et al. "Convalescent plasma therapy for COVID-19." World Journal of Advanced Research and Reviews 11, no. 3 (2021): 192–200. http://dx.doi.org/10.30574/wjarr.2021.11.3.0399.

Full text
Abstract:
The outbreak of severe acute respiratory syndrome COVID-19 caused by SARS-CoV-2 in China represents a significant threat to global health. Unfortunately, effective therapeutic drugs and vaccines to cure SARS-CoV-2 are still lacking. Convalescent Plasma therapy which induces passive immunization seems a successful treatment for COVID-19 patients and also proves to be of huge value in terms of saving the severely ill patient. Plasma therapy acts by Blocking the Virus (Neutralization), Enhancing Phagocytosis (Opsonization), Immune System Activation (Complement Activation), and finally killing Vir
APA, Harvard, Vancouver, ISO, and other styles
23

Heena, Bholaram Choudhary, Rajkumar Patekar Rohan, Pramod Jain Akshita, et al. "Convalescent plasma therapy for COVID-19." World Journal of Advanced Research and Reviews 11, no. 3 (2021): 192–200. https://doi.org/10.5281/zenodo.5563678.

Full text
Abstract:
The outbreak of severe acute respiratory syndrome COVID-19 caused by SARS-CoV-2 in China represents a significant threat to global health. Unfortunately, effective therapeutic drugs and vaccines to cure SARS-CoV-2 are still lacking. Convalescent Plasma therapy which induces passive immunization seems a successful treatment for COVID-19 patients and also proves to be of huge value in terms of saving the severely ill patient. Plasma therapy acts by Blocking the Virus (Neutralization), Enhancing Phagocytosis (Opsonization), Immune System Activation (Complement Activation), and finally killing Vir
APA, Harvard, Vancouver, ISO, and other styles
24

Avalueva, Avalueva E. B., Bakulin I. G. Bakulin, Skalinskaya M. I. Skalinskaya, Oganezova I. A. Oganezova, and Sitkin S. I. Sitkin. "Immunological serum and plasma markers for the diagnosis of inflammatory bowel disease." Therapy 7_2022 (October 14, 2022): 44–53. http://dx.doi.org/10.18565/therapy.2022.7.44-53.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Kellokoski, Eija, Seppo M. Pöykkö, Anna H. Karjalainen, et al. "Estrogen Replacement Therapy Increases Plasma Ghrelin Levels." Journal of Clinical Endocrinology & Metabolism 90, no. 5 (2005): 2954–63. http://dx.doi.org/10.1210/jc.2004-2016.

Full text
Abstract:
Ghrelin is a novel peptide hormone that has GH releasing activity and also other endocrine and metabolic functions. The purpose of this study was to investigate the effects of estrogen replacement therapy on plasma active ghrelin levels in 64 hysterectomized postmenopausal women receiving peroral estrogen (PE) or transdermal estrogen therapy for 6 months. Active ghrelin was measured using commercial RIA. Estrogen therapy increased plasma active ghrelin from 479 ± 118 to 521 ± 123 pg/ml (P = 0.002) among all the study subjects. PE therapy increased plasma ghrelin levels from 465 ± 99 to 536 ± 1
APA, Harvard, Vancouver, ISO, and other styles
26

IMANARI, TOSHIHIRO. "Technical problem in plasma exchange therapy." Japanese journal of extra-corporeal technology 16, no. 2 (1990): 8–17. http://dx.doi.org/10.7130/hokkaidoshakai.16.2_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Mina, Fahmida Begum, Mutasim Billah, Md Siddikur Rahman, et al. "Convalescent plasma: Alternative or promising therapy?" Journal of Global Antimicrobial Resistance 24 (March 2021): 246–48. http://dx.doi.org/10.1016/j.jgar.2021.01.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Uysal, Ayse, Mehmet Erkurt, Irfan Kuku, et al. "Convalescent plasma therapy in COVID-19." Medicine Science | International Medical Journal 11, no. 2 (2022): 920. http://dx.doi.org/10.5455/medscience.2021.09.292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Gupta, Aditya K., Helen J. Renaud, and Jeffrey A. Rapaport. "Platelet-rich Plasma and Cell Therapy." Dermatologic Clinics 39, no. 3 (2021): 429–45. http://dx.doi.org/10.1016/j.det.2021.04.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

"Plasma Therapy: An Alternative to Antibiotics?" Microbiology Journal 1, no. 2 (2011): 78. http://dx.doi.org/10.3923/mj.2011.78.78.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Nguyen, Trung C., and Yong Y. Han. "Plasma exchange therapy for thrombotic microangiopathies." Organogenesis 7, no. 1 (2011): 28–31. http://dx.doi.org/10.4161/org.7.1.14027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

COLLINS, P., R. AHAMAT, C. GREEN, and J. FERGUSON. "Plasma exchange therapy for solar urticaria." British Journal of Dermatology 134, no. 6 (1996): 1093–97. http://dx.doi.org/10.1046/j.1365-2133.1996.d01-908.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

COLLINS, P., R. AHAMAT, C. GREEN, and J. FERGUSON. "Plasma exchange therapy for solar urticaria." British Journal of Dermatology 134, no. 6 (1996): 1093–97. http://dx.doi.org/10.1111/j.1365-2133.1996.tb07949.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Aster, Richard H. "Plasma Therapy for Thrombotic Thrombocytopenic Purpura." New England Journal of Medicine 312, no. 15 (1985): 985–87. http://dx.doi.org/10.1056/nejm198504113121510.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Offner, F. "MYELOMA THERAPY: PURSUING THE PLASMA CELL." Acta Clinica Belgica 65, no. 3 (2010): 205–6. http://dx.doi.org/10.1179/acb.2010.045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Keidar, Michael, Alex Shashurin, Olga Volotskova, et al. "Cold atmospheric plasma in cancer therapy." Physics of Plasmas 20, no. 5 (2013): 057101. http://dx.doi.org/10.1063/1.4801516.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Komura, T., T. Taniguchi, T. Noda, M. Okajima, and S. Kaneko. "Efficacy of continuous plasma diafiltration therapy." Critical Care 18, Suppl 1 (2014): P400. http://dx.doi.org/10.1186/cc13590.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Sezer, Orhan. "Myeloma therapy - pursuing the plasma cell." European Journal of Haematology 83, no. 4 (2009): 389. http://dx.doi.org/10.1111/j.1600-0609.2009.01294.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Jassim, Muntadher Ghanem, Hussein Ali Mujbil, Azhar Awad Jabr, et al. "SKIN THERAPY USING COLD ATMOSPHERIC PLASMA." European Journal of Medical Genetics and Clinical Biology 1, no. 8 (2024): 394–412. https://doi.org/10.61796/jmgcb.v1i8.904.

Full text
Abstract:
Background: Maintaining skin integrity is essential for protecting against external agents, microorganisms, and dehydration, while also serving social and aesthetic functions. Recent advancements in skin care have introduced innovative technologies, including Cold Atmospheric Plasma (CAP), which shows promising results in dermatology. Specific Background: CAP technology, based on physical principles, has emerged as a novel approach in skin treatments, offering potential benefits for aging prevention and skin care. This interdisciplinary field encompasses physics, biology, chemistry, and bioche
APA, Harvard, Vancouver, ISO, and other styles
40

Triulzi, Darrell J. "The art of plasma transfusion therapy." Transfusion 46, no. 8 (2006): 1268–70. http://dx.doi.org/10.1111/j.1537-2995.2006.00923.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Vyssoulis, G. "Candesartan antihypertensive therapy decreases plasma homocystine." American Journal of Hypertension 14, no. 11 (2001): A69. http://dx.doi.org/10.1016/s0895-7061(01)01669-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

The Lancet Haematology. "The resurgence of convalescent plasma therapy." Lancet Haematology 7, no. 5 (2020): e353. http://dx.doi.org/10.1016/s2352-3026(20)30117-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

ROBINSON, J. "Etretinate: therapy for plasma cell vulvitis." Obstetrics & Gynecology 92, no. 4 (1998): 706. http://dx.doi.org/10.1016/s0029-7844(98)00238-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Guillaume, J. C., J. C. Roujeau, J. Revuz, and R. Touraine. "Plasma exchange therapy in bullous pemphigoid." Plasma Therapy and Transfusion Technology 8, no. 2 (1987): 131–36. http://dx.doi.org/10.1016/s0278-6222(87)80021-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

VYSSOULIS, G. "Irbesartan antihypertensive therapy decreases plasma homocysteine." American Journal of Hypertension 15, no. 4 (2002): A51. http://dx.doi.org/10.1016/s0895-7061(02)02401-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Saleh, Abdelaziz A., Leonard G. Dorey, Mitchell P. Dombrowski, Janie Hirata, and Eberhard F. Mammen. "Plasma fibronectin and estrogen replacement therapy." Thrombosis Research 75, no. 3 (1994): 319–22. http://dx.doi.org/10.1016/0049-3848(94)90242-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Cavenagh, J. "Myeloma therapy: pursuing the plasma cell." British Journal of Cancer 103, no. 1 (2010): 156. http://dx.doi.org/10.1038/sj.bjc.6605710.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

KAWAI, HIRONOBU, KOHEI MURAYAMA, HIROSHI HOSHIZAKI, et al. "PLASMA EXCHANGE THERAPY OF HEPATIC FAILURE." KITAKANTO Medical Journal 40, no. 1 (1990): 127–31. http://dx.doi.org/10.2974/kmj1951.40.127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

EMMERSON, B. T., R. B. GORDON, M. CROSS, and D. B. THOMSON. "PLASMA OXIPURINOL CONCENTRATIONS DURING ALLOPURINOL THERAPY." Rheumatology 26, no. 6 (1987): 445–49. http://dx.doi.org/10.1093/rheumatology/26.6.445.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Ding, Xu-long, and Peng Lei. "Plasma Replacement Therapy for Alzheimer’s Disease." Neuroscience Bulletin 36, no. 1 (2019): 89–90. http://dx.doi.org/10.1007/s12264-019-00394-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!